Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by 18F-FDG PET/CT Imaging

Background

There is evidence that metabolic disease burden in lymphoma influences patient outcome. However, the impact of disease severity on the cardiovascular system is unknown.

Objectives

The aim of this study was to examine whether lymphoma is associated with arterial inflammation by investigating the relationship between disease metabolic burden and arterial fluorodeoxyglucose (FDG) uptake.

Methods

Sixty-two chemotherapy-naïve patients with active Hodgkin’s or non-Hodgkin’s lymphoma were matched (2:1) to individual control groups of lymphoma patients previously treated and free of active disease. All groups underwent ¹⁸F-FDG position emission tomography–computed tomography imaging. Disease severity was quantified by metabolic tumor volume (MTV) and total lesion glycolysis corresponding to standardized uptake values (SUVs) ≥41% or ≥2.5 of the maximum SUV within lymphoma regions, and aortic FDG uptake was quantified through the target-to-background ratio (TBR). Inflammatory and disease severity biomarkers were also measured.

Results

MTV and total lesion glycolysis measurements were significantly correlated with inflammatory and disease biomarkers. Aortic TBR was higher in patients with active non-Hodgkin’s lymphoma compared with control subjects (median difference 0.51; 95% confidence interval [CI]: 0.28 to 0.78; p < 0.001). Similarly, patients with active Hodgkin’s lymphoma had higher values of aortic TBR compared with control subjects (median difference 0.31; 95% CI: 0.15 to 0.49; p < 0.001). In addition, aortic TBR was modestly increased in patients with stage III to IV disease compared with those with stage I to II disease (median aortic TBR: 2.23 [interquartile range: 2.01 to 2.54] vs. 2.06 [interquartile range: 1.83 to 2.27; p = 0.050). In multivariable analysis, aortic FDG uptake and MTV_≥2.5 values were independently associated (β = 0.425; 95% CI: 0.189 to 0.662; p = 0.001; R² = 0.208), as were aortic FDG uptake and MTV_≥41% (β = 0.407; 95% CI: 0.167 to 0.649, p = 0.001; R² = 0.191).

Conclusions

Aortic wall FDG uptake is related with disease severity indicative of a possible vascular effect of lymphoma. This work highlights a new potential role of molecular imaging in cardio-oncology for evaluating disease severity and its consequences on the vasculature.

Asymptomatic adult cystic lymphangioma of the spleen: case report and review of the literature

In the present report we describe a case of an asymptomatic splenic cystic lymphangioma in a 43 year-old female. Only a few cases of this benign tumor have been reported in adult patients so far. Clinical examination revealed a tender mass in the upper left quadrant of the abdomen. Abdominal ultrasound and CT-scan revealed a large well-defined splenic cystic mass surrounded by multiple peripheral cysts, all divided by thin septa. MRI confirmed these findings and excluded the possibility of malignant degeneration. Histologic examination permitted the accurate diagnosis to be made. Different imaging findings of this tumor have been described but only a few reports have focused on the value of MRI imaging.

Surgical treatment of non-parasitic hepatic cysts: report of 12 cases

OBJECTIVE

To present our experience of non-parasitic hepatic cysts.

DESIGN

Retrospective study.

SETTING

University Hospital, Greece.

SUBJECTS

12 consecutive patients with symptomatic non-parasitic hepatic cysts operated on during the 7-year period 1990-97 inclusive.

INTERVENTIONS

Wide unroofing of the hepatic cysts.

MAIN OUTCOME MEASURES

Persistence or recurrence of symptoms and recurrence of cysts.

RESULTS

Symptoms persisted or recurred in 2/12 patients and cysts recurred in 2/9 who had ultrasound scans.

CONCLUSION

Surgical treatment of non-parasitic hepatic cysts was effective and safe.